Why the study?
TMVR was developed as an alternative to surgery for patients with severe mitral regurgitation at high surgical risk, prompting a review of the state-of-the-art, technical characteristics, and early clinical experience.
What is the current state-of-the-art, technical characteristics, and early clinical experience of transcatheter mitral valve replacement (TMVR) in patients with severe mitral regurgitation at high surgical risk?
What is the current state-of-the-art, technical characteristics, and early clinical experience of transcatheter mitral valve replacement (TMVR) in patients with severe mitral regurgitation at high surgical risk?
TMVR is emerging as a promising alternative for high-risk patients with severe mitral regurgitation, though challenges like LVOTO and bleeding/thrombotic risks remain.
Answers are grounded in this paper and cite their sources.
TMVR warrants caution in high-risk patients due to complications; leaves open its role pending randomized data.
PURPOSE OF REVIEW: Transcatheter mitral valve replacement (TMVR) has been developed to address the need for an alternative therapeutic option to surgery in patients suffering from severe mitral regurgitation who are at high surgical risk. The present review illustrated the state-of-the-art of catheter-based mitral valve replacement evaluating technical characteristics and early clinical experience of different devices to outline prospects and challenges of TMVR. RECENT FINDINGS: Several devices are currently under clinical assessment. Early experience has demonstrated high procedural success of TMVR. However, TMVR faces several possible hurdles such as left ventricular outflow tract obstruction (LVOTO) after prosthesis deployment, access site complications, and thrombotic risk requiring anticoagulatory therapy. Future studies should assess long-term prosthesis stability, optimal anticoagulation regime, and occurrence of paravalvular leakage. The development of smaller TMVR prostheses suitable for transseptal implantation could overcome bleeding complications. In perspective, TMVR may emerge to a clinically relevant therapeutic approach for patients with severe MR at high surgical risk.
No takes yet. Share an insight, caveat, or question.
Rawish et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: